|
|
Volumn 360, Issue 1, 2009, Pages 86-87
|
|
Analyses of cancer data from three ezetimibe trials
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EZETIMIBE;
AZETIDINE DERIVATIVE;
HYPOCHOLESTEROLEMIC AGENT;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RISK;
CLINICAL TRIAL;
DRUG EXPOSURE;
DRUG SAFETY;
HUMAN;
LETTER;
NEOPLASM;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
CHEMICALLY INDUCED DISORDER;
HYPERCHOLESTEROLEMIA;
MORTALITY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RISK;
STATISTICAL ANALYSIS;
ANTICHOLESTEREMIC AGENTS;
AZETIDINES;
DATA INTERPRETATION, STATISTICAL;
HUMANS;
HYPERCHOLESTEROLEMIA;
NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK;
|
|
EID: 58249094504
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc082188 Document Type: Letter |
|
Times cited : (7)
|
|
References (1)
|
